Ranbaxy, one of India’s largest drugmakers, plans to spin off a research unit devoted to developing original medicines, as part of an effort to expand beyond its core generic drugs business.
Ranbaxy, one of India’s largest drugmakers, plans to spin off a research unit devoted to developing original medicines, as part of an effort to expand beyond its core generic drugs business.
